ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Wins Silver at ECCCSA for AI Innovation in Medical Information

RALEIGH, NC, January 31, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, has been awarded Silver in the "Greatest Impact of AI (In-house)" category at the prestigious European Contact Centre & Customer Service Awards (ECCCSA). This recognition underscores ProPharma’s leadership in leveraging artificial intelligence (AI) to transform Medical Information (MI) services and enhance customer engagement.

The ECCCSAs, recognized as Europe's largest and longest-running customer contact awards program, celebrate innovation and excellence in customer service. ProPharma’s AI-driven solutions have revolutionized Medical Information services by streamlining inquiries, improving response times, and ensuring the delivery of accurate, compliant, and high-quality medical information to healthcare professionals and patients worldwide.

"As the complexity of medical inquiries continues to grow, AI enables us to enhance efficiency while maintaining the highest standards of scientific accuracy and regulatory compliance," said Hannah Hunter, Senior Director, Medical Information at ProPharma. "This award reflects our ongoing commitment to leveraging AI to elevate the quality and accessibility of medical information for our clients and their patients."

By integrating AI into its medical information services, ProPharma has significantly enhanced operational performance, optimized response management, and provided valuable insights that drive better decision-making for pharmaceutical and biotech companies.

"This recognition affirms ProPharma's dedication to pushing the boundaries of innovation in Medical Information," said Rajul Jain, President, Medical Information at ProPharma. "We are harnessing AI not just to improve efficiency, but to transform how life sciences organizations deliver critical information, ensuring that patients and healthcare providers receive the most accurate and timely responses."

Winning in the 'Greatest Impact of AI (In-house)' category highlights ProPharma's pioneering role in AI implementation, reinforcing its position as a trusted partner for pharmaceutical, biotechnology, and medical device companies worldwide.

 

TAGS:

CPHI Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

Regulatory and Compliance excellence recognized for innovation across the product development lifecycle RALEIGH, NC, October 9, 2024: ProPharma, a leading global provider of regulatory, clinical, and...

ProPharma and PBL collaborate with CF Box

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Platform

First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable RALEIGH, May 2, 2024 – ProPharma, the leading global provider of regulatory, clinical,...

April 21, 2022

ProPharma Group Named Best Pharmaceutical Regulatory & Compliance Consultancy: 2022 Corporate Excellence Awards

ProPharma Group Named Best Pharmaceutical Regulatory & Compliance Consultancy: 2022 Corporate Excellence Awards: ProPharma Group is honored to be awarded "Best Pharmaceutical Regulatory & Compliance...